Coronavirus is a pathogen that hasbeen known to medicine for a long time with 39 different genotypes,which fall under the broad realm of Riboviria, which mainly target the human respiratory system.The novel coronavirus disease 2019is caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). This virus has an enveloped single-stranded positive strand RNA structure and it uses the spike projection as a key to enter cells, the S protein has great significance because of its function in receptor binding.This new coronavirus belongs to the beta-genus coronavirus, it has been reported that coronavirus disease 2019has 79.5% homologousity with SARS-CoV, and their receptors are angiotensin converting enzyme 2 (ACE2).Furthermore, several countries have started to treat coronavirus-infected patients with repurposed therapeutics such as HIV protease inhibitors (Ritonavir) and Kaletra, because clinical trials are taking a long time and there is no effective targeted treatment to cure the patient with the disease. This review article is questioning the role of Angiotensin converting enzyme inhibitors in COVID-19 infection severity and treatment., {"references":["1.\tAcharya, K. R., Sturrock, E. D., Riordan, J. F., & Ehlers, M. R. (2003). Ace revisited: a new target for structure-based drug design.. Nature Reviews Drug Discovery,, 2(11), 891- 902","Alkuraishy, H. M., Al-Gareeb, A. I., & Al-hussaniy, H. A. (2017). Doxorubicin-induced cardiotoxicity: molecular mechanism and protection by conventional drugs and natural products. Int J Clin Oncol Cancer Res, 2(2), 31-44.","Bourgonje, A. R., Abdulle, A. E., Timens, W., Hillebrands, J. L., Navis, G. J., Gordijn, S. J., . . . van Goor, H. (2020). Angiotensin‐converting enzyme 2 (ACE2), SARS‐CoV‐2 and the pathophysiology of coronavirus disease 2019 (COVID‐19). . The Journal of pathology,, 251(3), 228-248.","Chen, J., Lau, Y. F., Lamirande, E. W., Paddock, C. D., Bartlett, J. H., Zaki, S. R., & Subbarao, K. (2010). Cellular immune responses to severe acute respiratory syndrome coronavirus (SARS-CoV) infection in senescent BALB/c mice: CD4+ T cells are importa. Journal of virology, 84(3), 1289-1301.","Cushman, D. W., & Cheung, H. S. (1971). Cushman, D. W., & Cheung, H. S. (1971). Concentrations of angiotensin-converting enzyme in tissues of the rat. . Biochimica et Biophysica Acta (BBA)-Enzymology, 250(1), , 261-265.","Dhochak, N., Singhal, T., Kabra, S. K., & Lodha, R. .. (2020). Pathophysiology of COVID-19: why children fare better than adults?.. The Indian Journal of Pediatrics 87, 537-546., 87, 537-546.","Gallo‐Payet, N., & Battista, M. C. (2011). Steroidogenesis—adrenal cell signal transduction. . Comprehensive Physiology,, 4(3), 889-964.","Gao, L., Wang, W. Z., Wang, W., & Zucker, I. H. (2008). Imbalance of angiotensin type 1 receptor and angiotensin II type 2 receptor in the rostral ventrolateral medulla:. potential mechanism for sympathetic overactivity in heart failure. Hypertension, 52(4), 708-714.","Hirano, T., & Murakami, M. .. (2020). COVID-19: a new virus, but a familiar receptor and cytokine release syndrome. . Immunity, 52(5), 731-733. 10.\tHuang, Y., Yang, C., Xu, F., X., Xu, W., & Liu, S. W. (2020). Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19. . Acta Pharmacologica Sinica, 41(9),, 1141-1149.","Igase, M., Strawn, W. B., Gallagher, P. E., Geary, R. L., & Ferrario, C. M. (2005). Angiotensin II AT1 receptors regulate ACE2 and angiotensin-(1–7) expression in the aorta of spontaneously hypertensive rats. . American Journal of Physiology-Heart and Circulatory Physiology,, 289(3), H1013-H1019.","Ishola, A. A., Adewole, K. E., Tijjani, H., Abdulai, S. I., & Asogwa, N. T. (2021). Phylogenic analysis of coronavirus genome and molecular studies on potential anti- COVID-19 agents from selected FDA-approved drugs. Journal of Biomolecular Structure and Dynamics, 1-18.","Jiang, C., Yao, X., Zhao, Y., Wu, J., Huang, P., ................, & Pan, C. (2020). Comparative review of respiratory diseases caused by coronaviruses and influenza A viruses during epidemic season.. Microbes and infection, 22(6-7), 236-244.","Khan, S., Ali, A., Siddique, R., & Nabi, G. . (2020). Novel coronavirus is putting the whole world on alert. Journal of Hospital Infection, 104(3), 252-253.","Khan, Z., Ghafoor, D., Khan, A., Ualiyeva, D., Khan, S. A., Bilal, H., . . . Sajjad, W. (2020). Diagnostic approaches and potential therapeutic options for coronavirus disease (COVID-19).. New microbes and new infections, 100770.","Kumar, S., Zhi, K., Mukherji, A., & Gerth, K. (2020). Repurposing antiviral protease inhibitors using extracellular vesicles for potential therapy of COVID-19. . Viruses, 12(5), 486.","Lai, C. C., Shih, T. P., Tang, H. J., & Hsueh, P. R. (2020). Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. International journal of antimicrobial agents, 55(3), 105924.","Lax, S. F., Skok, K., Zechner, P., Kessler, H. H., Kaufmann, N., Koelblinger, C. .., & Trauner, M. (2020). Pulmonary arterial thrombosis in COVID-19 with fatal outcome: results from a prospective, single-center, clinicopathologic case series. Annals of internal medicine,, 173(5), 350-361.","Al-hassany HA, AH A, Naji M. Tumor diagnosis by genetic markers protein P-53, p16, C- MYC, N-MYC, protein K-Ras, and gene her-2 Neu is this possible?. Pakistan Journal of Medical and Health Sciences. 2021;15(8):2350-4","Moores, L. K., Tritschler, T., Brosnahan, S., Carrier, M., Collen, J. F., Doerschug, K., . . . Wells, P. (2020). Prevention, diagnosis, and treatment of VTE in patients with coronavirus disease 2019: CHEST guideline and expert panel report. , 1. Chest, 158(3), 1143-1163.","Nguyen Dinh Cat, A., Montezano, A. C., Burger, D., & Touyz, R. M. (2013). Angiotensin II, NADPH oxidase, and redox signaling in the vasculature.. Antioxidants & redox signaling, 19(10), 1110-1120.","Ni, W., Yang, X., Yang, D., Bao, J., Li, R., Xiao, Y., . . . Gao, Z. .. (2020). Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19.. Critical Care, 24(1), 1-10","Overlack, A. (1996). ACE inhibitor-induced cough and bronchospasm. . Drug safety,, 15(1), 72-78.","Patil, R., Chikhale, R., Khanal, P., Gurav, N., Ayyanar, M., Sinha, S., . . . Gurav, S. S. (2021). Computational and network pharmacology analysis of bioflavonoids as possible natural antiviral compounds in COVID-19. Informatics in medicine unlocked, 22, 100504.","Shereen, M. A., Khan, S., Kazmi, A., Bashir, N., & Siddique, R. (2020). COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses. . Journal of advanced research, , 24, 91-98.","Sridharan, G. K., Kotagiri, R., Chandiramani, V. H., Mohan, B. P., Vegunta, R., Vegunta, R., & Rokkam, V. R. (2020). COVID-19 and avoiding Ibuprofen. How good is the evidence?.. American journal of therapeutics, 27(4), e400-e402.","Steckelings, U. M., Artuc, M., Wollschläger, T., Wiehstutz, S., & Henz, B. M. (2001). Angiotensin-converting enzyme inhibitors as inducers of adverse cutaneous reactions. Acta dermato-venereologica, , 81(5).","Wang, H. Y., Li, X. L., Yan, Z. R., Sun, X. P., Han, J., & Zhang, B. W. (2020). Potential neurological symptoms of COVID-19. . Therapeutic advances in neurological disorders,, 13, 1756286420917830.","Ali AS, Hajleh MN, Akour A, Shalan N, Jaber N, Al-Halaseh LK, Alzweiri M. Investigation into the prophylactic and therapeutic activity of coenzyme Q10 against COVID-19. Tropical Journal of Pharmaceutical Research. 2021 Dec 13;20(11):2387-93.","Yan, T., Xiao, R., & Lin, G. (2020). Angiotensin‐converting enzyme 2 in severe acute respiratory syndrome coronavirus and SARS‐CoV‐2: A double‐edged sword?.. The FASEB Journal,, 34(5), 6017-6026.","Al-Kuraishy HM, Al-Gareeb AI, Al-Hussaniy HA, Al-Harcan NA, Alexiou A, Batiha GE. Neutrophil Extracellular Traps (NETs) and Covid-19: A new frontiers for therapeutic modality. International immunopharmacology. 2022 Jan 6:108516.","Al-hussaniy HA, Altalebi RR, Alburagheef A, Abdul-Amir AG. The Use of PCR for Respiratory Virus Detection on the Diagnosis and Treatment Decision of Respiratory Tract Infections in Iraq. J Pure Appl Microbiol. 2022. 34.\tALZobaidy MA, AlbuRghaif AH, Alhasany HA, Naji MA. Angiotensin-Converting Enzyme Inhibitors May Increase Risk of Severe COVID-19 Infection. Annals of the Romanian Society for Cell Biology. 2021 Jul 16;25(6):17843-9."]}